[毒素A和牛氨基酶氧化剂的连续使用,用于纠正中风后的性]

相关实验视频

Updated: May 24, 2025

07:05

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

22.7K

D A Krasavina¹, D O Ivanov¹, O R Orlova²

¹Saint Petersburg State Pediatric Medical University, Saint-Petersburg, Russia.

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

|March 6, 2025

概括

这项案例研究表明,A型肉毒素和阿佐克西默牛氨基酶有效治疗缺血性中风后的性. 联合治疗改善了69岁患者的肌肉弹性和运动功能.

科学领域:

神经学神经学
康复医学康复医学康复医学
临床案例研究临床案例研究

背景情况:

缺血性中风可能导致半衰和性,影响运动功能.
和收缩形成在中风后的康复过程中存在重大挑战.
毒素A型 (BTA) 是一种被公认的治疗肌肉的方法.

研究的目的:

为了呈现一种临床案例,结合毒素A型 (BTA) 和阿佐克西默牛氨基酶 (BA) 治疗后性缺血性中风性.
评估这种联合治疗方法的安全性,耐受性和有效性.
评估对肌肉度,组织结构和运动功能的影响.

主要方法:

一个69岁的病人与右侧半衰减后缺血性中风治疗.
毒素A型 (incobotulinumtoxinA) 在超声波指导下进行.
在BTA治疗后,阿佐克西默牛氨基酶被注射到纤维化肩膀肌肉中.
使用修改的阿什沃思尺度 (MAS),阴影测量和电肌图学来监测治疗效果.

主要成果:

毒素A型注射导致上肢性 (MAS尺度) 的减少.
随后的阿佐克西默牛氨基酶应用导致肌肉组织结构的改变和肌肉度的降低.
结合疗法表现出良好的耐受性和有效性,用于控制缩形成的性.
观察到肌肉弹性和运动功能的改善.

结论:

一贯使用甲型肉毒素和氧化物牛氨基酶对中风后性是安全有效的.
阿佐克西默牛氨基酶通过减少纤维化和改善肌肉弹性来增强肉类治疗的效果.
这种综合方法为改善病患中风后动和收缩的运动功能提供了有希望的策略.

关键词:

一种类型A的肉毒毒素.牛hyaluronidase的阿佐克西默的使用情况缺血性中风中风康复康复康复康复康复康复性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性等.

相关概念视频

01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

642

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...

642

01:31

Skeletal Muscle Relaxants: Therapeutic Uses

452

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...

452

01:24

Centrally Acting Muscle Relaxants: Therapeutic Uses

603

Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...

603

01:29

Spasmolytic Agents: Chemical Classification

848

Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...

848

01:28

Classification of Skeletal Muscle Relaxants

2.3K

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...

2.3K

01:09

Peripherally and Centrally Acting Muscle Relaxants: A Comparison

3.1K

Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...